- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 233/74 - Two oxygen atoms, e.g. hydantoin with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to other ring members
Patent holdings for IPC class C07D 233/74
Total number of patents in this class: 80
10-year publication summary
|
6
|
6
|
10
|
8
|
6
|
8
|
8
|
3
|
3
|
2
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Cv6 Therapeutics (NI) Limited | 32 |
10 |
| Bayer Cropscience AG | 2040 |
3 |
| Technion Research & Development Foundation Ltd. | 1214 |
3 |
| University of South Alabama | 125 |
3 |
| Foresee Pharmaceuticals USA Inc., DBA Foresee Pharmaceuticals Co. Ltd. | 21 |
3 |
| The Regents of the University of California | 19961 |
2 |
| The Board of Trustees of the University of Illinois | 2702 |
2 |
| University of South Florida | 1834 |
2 |
| Endorecherche, Inc. | 24 |
2 |
| H. Lee Moffitt Cancer Center and Research Institute, Inc. | 950 |
2 |
| The Scripps Research Institute | 1346 |
2 |
| Sanofi | 4072 |
2 |
| F. Hoffmann-La Roche AG | 7947 |
1 |
| Hoffmann-La Roche Inc. | 3439 |
1 |
| Abbott Laboratories | 2402 |
1 |
| Hewlett-Packard Development Company, L.P. | 25864 |
1 |
| Sumitomo Chemical Company, Limited | 9043 |
1 |
| Shin-Etsu Chemical Co., Ltd. | 5669 |
1 |
| DSM IP Assets B.V. | 5585 |
1 |
| Abbvie Inc. | 1800 |
1 |
| Other owners | 36 |